Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.68
$0.023.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 72.00% | -54.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.00% | -42.03% | |||
| Operating Income | -23.00% | 42.03% | |||
| Income Before Tax | -11.40% | 36.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.40% | 36.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.40% | 36.67% | |||
| EBIT | -23.00% | 42.03% | |||
| EBITDA | -10.30% | 42.05% | |||
| EPS Basic | 10.17% | 68.07% | |||
| Normalized Basic EPS | -1.60% | 68.07% | |||
| EPS Diluted | 9.96% | 68.07% | |||
| Normalized Diluted EPS | -1.60% | 68.07% | |||
| Average Basic Shares Outstanding | 24.01% | 98.36% | |||
| Average Diluted Shares Outstanding | 24.01% | 98.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||